Search
Patexia Research
Case number 2:21-cv-00564

BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. QILU PHARMA INC. > Documents

Date Field Doc. No.Description (Pages)
May 3, 2021 4 Notice of Voluntary Dismissal (2)
Docket Text: NOTICE of Voluntary Dismissal by BOEHRINGER INGELHEIM INTERNATIONAL GMBH, BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG, BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (GRAY, KYLE)
Apr 1, 2021 3 Notice (Other) (1)
Docket Text: NOTICE THAT, UNLESS SERVICE OF THE COMPLAINT IS MADE ON DEFENDANT BY MAY 10, 2021, THE CASE WILL BE DISMISSED WITHOUT PREJUDICE FOR LACK OF PROSECUTION UNLESS GOOD CAUSE FOR THE FAILURE TO COMPLY WITH RULE 4(m) IS SHOWN PRIOR TO THAT TIME. (ENTERED 4/01/2021)(ja,)
Feb 8, 2021 N/A Summons Issued (0)
Docket Text: Summons Issued as to QILU PHARMA INC.. Forwarded To: PLAINTIFF'S COUNSEL on 2/8/21 (amas, )
Feb 5, 2021 1 Complaint (Attorney) (21)
Docket Text: COMPLAINT against QILU PHARMA INC. ( Filing fee $ 402 receipt number 0313-14897056.), filed by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM INTERNATIONAL GMBH, BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG. (Attachments: # (1) Exhibit Exhibits 1-4, # (2) Summons)(HALL, CHRISTOPHER) Modified on 2/8/2021 (fb).
Feb 5, 2021 1 Exhibit Exhibits 1-4 (68)
Feb 5, 2021 1 Summons (2)
Feb 5, 2021 2 Disclosure Statement Form (2)
Docket Text: Disclosure Statement Form pursuant to FRCP 7.1 including C.H. Beohringer Sohn AG & Co. KG by BOEHRINGER INGELHEIM INTERNATIONAL GMBH, BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG, BOEHRINGER INGELHEIM PHARMACEUTICALS, INC..(HALL, CHRISTOPHER)
Feb 5, 2021 1 Main Document (21)
Docket Text: COMPLAINT against QILU PHARMA INC. ( Filing fee $ 402 receipt number 0313-14897056.), filed by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM INTERNATIONAL GMBH, BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG. (Attachments: # (1) Exhibit Exhibits 1-4, # (2) Summons)(HALL, CHRISTOPHER) Modified on 2/8/2021 (fb).
Feb 5, 2021 1 Complaint?* (1)
Menu